BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 10639438)

  • 1. Enzymatic properties of dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis and its participation in virulence.
    Kumagai Y; Konishi K; Gomi T; Yagishita H; Yajima A; Yoshikawa M
    Infect Immun; 2000 Feb; 68(2):716-24. PubMed ID: 10639438
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptidase activity of dipeptidyl aminopeptidase IV produced by Porphyromonas gingivalis is important but not sufficient for virulence.
    Kumagai Y; Yajima A; Konishi K
    Microbiol Immunol; 2003; 47(10):735-43. PubMed ID: 14605440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism for connective tissue destruction by dipeptidyl aminopeptidase IV produced by the periodontal pathogen Porphyromonas gingivalis.
    Kumagai Y; Yagishita H; Yajima A; Okamoto T; Konishi K
    Infect Immun; 2005 May; 73(5):2655-64. PubMed ID: 15845467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Importance of biofilm formation and dipeptidyl peptidase IV for the pathogenicity of clinical Porphyromonas gingivalis isolates.
    Clais S; Boulet G; Kerstens M; Horemans T; Teughels W; Quirynen M; Lanckacker E; De Meester I; Lambeir AM; Delputte P; Maes L; Cos P
    Pathog Dis; 2014 Apr; 70(3):408-13. PubMed ID: 24532232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological studies on virulence of dipeptidyl aminopeptidase IV (DPPIV) of Porphyromonas gingivalis in a mouse abscess model: use of a DPPIV-deficient mutant.
    Yagishita H; Kumagai Y; Konishi K; Takahashi Y; Aoba T; Yoshikawa M
    Infect Immun; 2001 Nov; 69(11):7159-61. PubMed ID: 11598093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emerging family of proline-specific peptidases of Porphyromonas gingivalis: purification and characterization of serine dipeptidyl peptidase, a structural and functional homologue of mammalian prolyl dipeptidyl peptidase IV.
    Banbula A; Bugno M; Goldstein J; Yen J; Nelson D; Travis J; Potempa J
    Infect Immun; 2000 Mar; 68(3):1176-82. PubMed ID: 10678923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Participation of the secreted dipeptidyl and tripeptidyl aminopeptidases in asaccharolytic growth of Porphyromonas gingivalis.
    Oda H; Saiki K; Tonosaki M; Yajima A; Konishi K
    J Periodontal Res; 2009 Jun; 44(3):362-7. PubMed ID: 19076991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence analysis of the Porphyromonas gingivalis dipeptidyl peptidase IV gene.
    Kiyama M; Hayakawa M; Shiroza T; Nakamura S; Takeuchi A; Masamoto Y; Abiko Y
    Biochim Biophys Acta; 1998 Mar; 1396(1):39-46. PubMed ID: 9524216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alanine aminopeptidase and dipeptidyl peptidase IV in saliva of chronic periodontitis patients.
    Aemaimanan P; Sattayasai N; Wara-aswapati N; Pitiphat W; Suwannarong W; Prajaneh S; Taweechaisupapong S
    J Periodontol; 2009 Nov; 80(11):1809-14. PubMed ID: 19905950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. N-linked glycosylation of dipeptidyl peptidase IV (CD26): effects on enzyme activity, homodimer formation, and adenosine deaminase binding.
    Aertgeerts K; Ye S; Shi L; Prasad SG; Witmer D; Chi E; Sang BC; Wijnands RA; Webb DR; Swanson RV
    Protein Sci; 2004 Jan; 13(1):145-54. PubMed ID: 14691230
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histoplasma capsulatum encodes a dipeptidyl peptidase active against the mammalian immunoregulatory peptide, substance P.
    Cooper KG; Zarnowski R; Woods JP
    PLoS One; 2009; 4(4):e5281. PubMed ID: 19384411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of RgpA, RgpB, and Kgp proteinases in virulence of Porphyromonas gingivalis W50 in a murine lesion model.
    O'Brien-Simpson NM; Paolini RA; Hoffmann B; Slakeski N; Dashper SG; Reynolds EC
    Infect Immun; 2001 Dec; 69(12):7527-34. PubMed ID: 11705929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trypsin-like protease activity of Porphyromonas gingivalis as a potential virulence factor in a murine lesion model.
    Kesavalu L; Holt SC; Ebersole JL
    Microb Pathog; 1996 Jan; 20(1):1-10. PubMed ID: 8692006
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Porphyromonas gulae Has Virulence and Immunological Characteristics Similar to Those of the Human Periodontal Pathogen Porphyromonas gingivalis.
    Lenzo JC; O'Brien-Simpson NM; Orth RK; Mitchell HL; Dashper SG; Reynolds EC
    Infect Immun; 2016 Sep; 84(9):2575-85. PubMed ID: 27354442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Virulence of a Porphyromonas gingivalis W83 mutant defective in the prtH gene.
    Fletcher HM; Schenkein HA; Morgan RM; Bailey KA; Berry CR; Macrina FL
    Infect Immun; 1995 Apr; 63(4):1521-8. PubMed ID: 7890419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CPG70 is a novel basic metallocarboxypeptidase with C-terminal polycystic kidney disease domains from Porphyromonas gingivalis.
    Chen YY; Cross KJ; Paolini RA; Fielding JE; Slakeski N; Reynolds EC
    J Biol Chem; 2002 Jun; 277(26):23433-40. PubMed ID: 11976326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IS195, an insertion sequence-like element associated with protease genes in Porphyromonas gingivalis.
    Lewis JP; Macrina FL
    Infect Immun; 1998 Jul; 66(7):3035-42. PubMed ID: 9632563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A peptide domain on gingipain R which confers immunity against Porphyromonas gingivalis infection in mice.
    Genco CA; Odusanya BM; Potempa J; Mikolajczyk-Pawlinska J; Travis J
    Infect Immun; 1998 Sep; 66(9):4108-14. PubMed ID: 9712755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Production of monoclonal antibody inhibiting dipeptidylaminopeptidase IV activity of Porphyromonas gingivalis.
    Teshirogi K; Hayakawa M; Ikemi T; Abiko Y
    Hybrid Hybridomics; 2003 Jun; 22(3):147-51. PubMed ID: 12954099
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Crystal structure of Porphyromonas gingivalis dipeptidyl peptidase 4 and structure-activity relationships based on inhibitor profiling.
    Rea D; Van Elzen R; De Winter H; Van Goethem S; Landuyt B; Luyten W; Schoofs L; Van Der Veken P; Augustyns K; De Meester I; Fülöp V; Lambeir AM
    Eur J Med Chem; 2017 Oct; 139():482-491. PubMed ID: 28826083
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.